🇺🇸 FDA
Pipeline program

GWP42003-P

GWEP15100 Open-label Extension

Phase 3 small_molecule completed

Quick answer

GWP42003-P for Infantile Spasms is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Infantile Spasms
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials